Parametric Portfolio Associates’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.1M | Buy |
365,354
+154,978
| +74% | +$465K | ﹤0.01% | 2737 |
|
|
2021
Q4 | $968K | Sell |
210,376
-99,560
| -32% | -$458K | ﹤0.01% | 2797 |
|
|
2021
Q3 | $1.95M | Buy |
309,936
+5,634
| +2% | +$35.4K | ﹤0.01% | 2458 |
|
|
2021
Q2 | $1.82M | Buy |
304,302
+44,730
| +17% | +$268K | ﹤0.01% | 2486 |
|
|
2021
Q1 | $1.64M | Buy |
259,572
+68,167
| +36% | +$431K | ﹤0.01% | 2909 |
|
|
2020
Q4 | $1.08M | Buy |
191,405
+47,327
| +33% | +$267K | ﹤0.01% | 3012 |
|
|
2020
Q3 | $839K | Sell |
144,078
-8,758
| -6% | -$51K | ﹤0.01% | 3028 |
|
|
2020
Q2 | $1.1M | Buy |
152,836
+22,487
| +17% | +$162K | ﹤0.01% | 2868 |
|
|
2020
Q1 | $610K | Sell |
130,349
-222,879
| -63% | -$1.04M | ﹤0.01% | 3058 |
|
|
2019
Q4 | $2.83M | Buy |
353,228
+255,596
| +262% | +$2.05M | ﹤0.01% | 2456 |
|
|
2019
Q3 | $672K | Sell |
97,632
-5,395
| -5% | -$37.1K | ﹤0.01% | 3230 |
|
|
2019
Q2 | $855K | Sell |
103,027
-42,171
| -29% | -$350K | ﹤0.01% | 3126 |
|
|
2019
Q1 | $1.44M | Sell |
145,198
-94,495
| -39% | -$939K | ﹤0.01% | 2834 |
|
|
2018
Q4 | $1.83M | Sell |
239,693
-8,542
| -3% | -$65.4K | ﹤0.01% | 2638 |
|
|
2018
Q3 | $4.32M | Sell |
248,235
-19,012
| -7% | -$331K | ﹤0.01% | 2144 |
|
|
2018
Q2 | $2.54M | Buy |
267,247
+196,151
| +276% | +$1.86M | ﹤0.01% | 2524 |
|
|
2018
Q1 | $311K | Buy |
+71,096
| New | +$311K | ﹤0.01% | 3561 |
|